DEA schedule
Is fingolimod a controlled substance?
Federal schedule for fingolimod from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Fingolimod is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and fingolimod is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted fingolimod?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 23 prescription listings from 22 labelers, none with a DEA schedule |
| DEA controlled substances list | fingolimod is not on the list |
Fingolimod NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0078-0965 | Gilenya | capsule | .25 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0607 | Gilenya | capsule | .5 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0480-7820 | Fingolimod | capsule | .5 mg/1 | Teva Pharmaceuticals, Inc. | None |
| 31722-889 | Fingolimod | capsule | .5 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 42291-048 | Fingolimod | capsule | .5 mg/1 | AvKARE | None |
| 43547-003 | FINGOLIMOD | capsule | .5 mg/1 | Solco Healthcare US, LLC | None |
| 43598-285 | Fingolimod | capsule | .5 mg/1 | Dr. Reddy's Laboratories Inc | None |
| 46708-228 | Fingolimod | capsule | .5 mg/1 | Alembic Pharmaceuticals Limited | None |
| 60505-4332 | Fingolimod | capsule | .5 mg/1 | Apotex Corp. | None |
| 62332-228 | Fingolimod | capsule | .5 mg/1 | Alembic Pharmaceuticals Inc. | None |
| 62756-064 | Fingolimod | capsule | .5 mg/1 | Sun Pharmaceutical Industries, Inc. | None |
| 64980-449 | fingolimod | capsule | .5 mg/1 | Rising Pharma Holdings, Inc. | None |
| 65862-952 | FINGOLIMOD | capsule | .5 mg/1 | Aurobindo Pharma Limited | None |
| 67877-476 | Fingolimod | capsule | .5 mg/1 | Ascend Laboratories, LLC | None |
| 68382-912 | Fingolimod | capsule | .5 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 68462-166 | fingolimod | capsule | .5 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 70377-019 | FINGOLIMOD | capsule | .5 mg/1 | Biocon Pharma Inc. | None |
| 70771-1603 | Fingolimod | capsule | .5 mg/1 | Zydus Lifesciences Limited | None |
| 72205-227 | Fingolimod | capsule | .5 mg/1 | Novadoz Pharmaceuticals LLC | None |
| 72865-257 | Fingolimod | capsule | .5 mg/1 | XLCare Pharmaceuticals Inc. | None |
| 82009-143 | FINGOLIMOD | capsule | .5 mg/1 | Quallent Pharmaceuticals Health LLC | None |
| 82249-385 | Fingolimod | capsule | .5 mg/1 | CivicaScript LLC | None |
| 16729-342 | FINGOLIMOD HYDROCHLORIDE | capsule | .5 mg/1 | Accord Healthcare Inc. | None |
Questions
Is fingolimod a controlled substance?
No. Fingolimod is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and fingolimod is not on the DEA controlled substances list.
Is fingolimod a narcotic?
No. Fingolimod is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Sphingosine 1-phosphate Receptor Modulator.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.